CSIMarket
 


Coherus Biosciences inc   (CHRS)
Other Ticker:  
 


Coherus Biosciences Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CHRS Gross Profit Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 101.81 % 64.16 % -2.39 % -46.04 % -38.19 %
Seq. Revenue Change 22.74 % 27 % 81.02 % -28.48 % -0.16 %
Revenue In Millions $91.52 $74.57 $58.72 $32.44 $45.35
Gross Profit Margin 7.6 % 56.14 % 57.68 % 47.98 % 68.68 %
Gross Profit Margin Total Ranking # 2732 # 2248 # 2292 # 2654 # 2160
Gross Profit In Millions $6.96 $41.87 $33.87 $15.56 $31.15
Y / Y Gross Profit Change -77.67 % 310.84 % -30.7 % -69.33 % -49.16 %
Seq. Gross Profit Change -83.38 % 23.61 % 117.63 % -50.04 % 205.69 %


Commenting fourth Quarter 2023 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 7.6 % due to increase in Cost of Sales and despite Revenue increase of 22.74 % to $92 millions.
Coherus Biosciences inc achieved highest Gross Profit Margin in IV. Quarter

Observing fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 51 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated compare to previous quarter from 2248 to 2732.
Learn about Gross Margin
CHRS's Gross Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 52
Healthcare Sector # 379
Overall # 2730

Gross Profit Margin Statistics
High Average Low
102.28 % 83.91 % 7.6 %
(Dec 31 2019)   (Dec 31 2023)




Other Gross Profit Margin Profitability Ratios
CHRS's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CHRS's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CHRS's Competitors
Gross Profit Margin Profit Margin for Coherus Biosciences Inc 's Suppliers
Gross Profit Margin Profit Margin for CHRS's Customers

You may also want to know
CHRS's Annual Growth Rates CHRS's Profitability Ratios CHRS's Asset Turnover Ratio CHRS's Dividend Growth
CHRS's Roe CHRS's Valuation Ratios CHRS's Financial Strength Ratios CHRS's Gross Profit Growth
CHRS's Roa CHRS's Inventory Turnover Ratio CHRS's Growth Rates CHRS's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2023 MRQ Gross ProfitDec 31 2023 MRQ Revenue
Protalix Biotherapeutics inc   15.54 %$ 1.630 $ 10.486 
Elutia inc   13.80 %$ 0.901 $ 6.530 
Recursion Pharmaceuticals Inc   9.28 %$ 1.011 $ 10.891 
Coherus Biosciences inc   7.60 %$ 6.957 $ 91.524 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com